Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Reductase
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Inflammation
    (1)
  • Metabolism
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

ono-2235

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Epalrestat
    ONO2235
    T145882159-09-9
    Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited